Fortrea Holdings INC 8-K filings

Fortrea Holdings Inc. announced its second quarter 2026 financial results, reporting $678.2 million in revenue and increasing its full-year guidance.

Fortrea Holdings Inc. reports the resignation of its Chief Accounting Officer and outlines the transition plan for its Chief Financial Officer, including interim appointments and severance details.

Fortrea has named industry veteran Jason Knoblauch as its new Chief Financial Officer, effective July 6, 2026, succeeding Jill McConnell.

Fortrea Holdings Inc. shareholders successfully elected directors, ratified auditors, and approved executive compensation at the 2026 Annual Meeting.

Fortrea Holdings Inc. announced its first quarter 2026 financial results, reporting revenues of $636.5 million and affirming its full-year 2026 guidance.

Fortrea Holdings Inc. reported full-year 2025 revenues of $2.72 billion and a significant GAAP net loss, while providing 2026 revenue and adjusted EBITDA guidance.

Fortrea Holdings Inc. announced the successful expiration of its debt tender offer, repurchasing $75.7 million of its 7.500% Senior Secured Notes due 2030.

Fortrea Holdings Inc. reported third-quarter 2025 financial results, showing increased revenue and improved GAAP net loss, but a decline in adjusted EBITDA, while raising full-year revenue guidance.

Fortrea Holdings Inc. announced the appointment of William J. Sharbaugh, an experienced healthcare executive, to its Board of Directors, effective September 22, 2025.

Fortrea Holdings Inc. amended its 2025 Inducement Award Plan, reserving an additional 2.2 million shares for new employee grants.

Fortrea Holdings Inc. reported increased revenues for Q2 2025 and raised full-year revenue guidance, despite a significant non-cash goodwill impairment charge leading to a GAAP net loss.

Fortrea Holdings Inc. announced the successful approval of an amended incentive plan and the election of Class II Directors at its 2025 Annual Meeting of Stockholders.

Fortrea Holdings Inc. has adopted a limited-duration stockholder rights plan to protect shareholder value and ensure fair treatment in potential takeover scenarios, citing significant stock price dislocation and third-party interest.

Fortrea Holdings Inc. announced the appointment of Anshul Thakral as its new President and Chief Executive Officer, effective August 4, 2025, succeeding interim CEO Peter M. Neupert who will continue as Chairman of the Board.

Fortrea Holdings Inc. amends its previous 8-K filing to disclose the appointment of Erin L. Russell to the Audit Committee of the Board, effective May 13, 2025.

Fortrea's Q1 2025 results reveal a revenue decrease and a substantial net loss due to a non-cash goodwill impairment charge, alongside the announcement of a CEO transition.

Thomas Pike is stepping down as Fortrea's CEO, with Peter M. Neupert appointed as Interim CEO, effective May 13, 2025.

Fortrea Holdings Inc. appoints Erin L. Russell as a Class II director, effective March 7, 2025, pursuant to an agreement with Starboard Value LP.

Fortrea's Q4 2024 results show a net loss despite a strong book-to-bill ratio, and the company issues 2025 revenue and adjusted EBITDA guidance below 2024 actuals.

Fortrea Holdings Inc. and Starboard Value LP reach an agreement, resulting in the appointment of Erin L. Russell to Fortrea's Board of Directors and a cooperation agreement between the two entities.

Fortrea's third quarter results show a decrease in revenue year-over-year but an increase in adjusted EBITDA sequentially, alongside a strong book-to-bill ratio.

Fortrea Holdings Inc. has amended its previous 8-K filing to disclose the committee assignments for newly appointed board member, Machelle Sanders.

Fortrea's Q2 2024 results show a net loss despite progress in strategic initiatives, including debt reduction and divestitures.

Fortrea Holdings Inc. has appointed Robert Parks as its new Chief Accounting Officer, effective in August 2024, succeeding Amanda Warren.

Fortrea Holdings has significantly reduced its debt by $275 million through repayments using proceeds from a recent divestiture and a receivables securitization program.

Fortrea Holdings Inc. issued an amended 8-K filing to correct non-GAAP financial information for the trailing twelve months ended March 31, 2024, and provided an updated corporate presentation with Q1 2024 results.

Fortrea has finalized the sale of its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners for a total consideration of $340 million.

Fortrea Holdings Inc. released its Q1 2024 earnings presentation, highlighting a solid demand environment and progress on strategic initiatives, while also showing a decrease in revenue and adjusted EBITDA compared to the same period last year.

Fortrea Holdings Inc. has appointed Machelle Sanders to its Board of Directors and held its 2024 Annual Meeting of Stockholders, where key proposals were voted on.

Fortrea's first quarter of 2024 saw a revenue decrease and a net loss, but the company is progressing with its planned divestiture and focusing on future growth.